baber/WOPTO huggingface dataset:
Patent HU-0001832-A3 (HU)
Title: Polycyclic phthalazin derivatives, their use for ppolycyclic phthalazin derivatives, their use for producing pharmaceutical compositions and pharmaceuroducing pharmaceutical compositions and pharmaceutical compositions containing the compounds tical compositions containing the compounds
IPC: C07D237/32
Filed: 1997-07-09
Abstract: PCT No. PCT/FI96/03632 Sec. 371 Date Jan. 28, 2000 Sec. 102(e) Date Jan. 28, 2000 PCT Filed Jul. 9, 1997 PCT Pub. No. WO98/07706 PCT Pub. Date Feb. 26, 1998Polycyclic phthalazines, in particular 2-substituted maduraphthalazines (10,12,15,16-tetrahydroxy-8-methoxy-11-methyl-1,9,14-trioxo-1,2,6,7,9,14-hexahydronaphthaceno-1,2-g-phthalazines), of formula I and their use against gram-positive bacterial strains, particularly against multi-resistant staphylococci (MRSA) and against glycopeptide-resistant, for example vancomycin-resistant, enterococci. The polycyclic phthalazines are thus suitable for preparing anti-bacterially effective pharmaceutical compositions. In formula I, R1 is carboxyalkyl or carboxyaryl, and R2 and R3 represent H or acyl (for example CO-alkyl or COO-alkyl), with R1 being different from optionally substituted carboxyphenyl when R3 represents C1-8 alkanoyl. The invention also relates to salts, amides and esters of compounds of formula I.
Patent HU-0004457-A3 (HU)
Title: Angiogenesis inhibiting thiadiazolyl-pyridazine derivatives, process for producing them and pharmaceutical compositions containing the same
IPC: C07D417/04
Filed: 1998-06-22
Abstract: This invention concerns compounds of formula (I), the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein R<1> is hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, amino, mono- or di(C1-6alkyl)amino, Ar<1>, Ar<1>-NH-, C3-6cycloalkyl, hydroxymethyl or benzyloxymethyl; R<2> and R<3> are hydrogen, or taken together may form a bivalent radical of formula -CH=CH-CH=CH-; R<4>, R<5> and R<6> are each independently selected from hydrogen, halo, C1-6alkyl, C1-6alkyloxy, trifluoromethyl, nitro, amino, cyano, azido, C1-6alkyloxyC1-6alkyl, C1-6alkylthio, C1-6alkyloxycarbonyl or Het<1>; or when R<4> and R<5> are adjacent to each other they may be taken together to form a radical of formula -CH=CH-CH=CH-; A is a bivalent radical of formula NR<7>, NR<7>-Alk<1>-X-, NR<7>-Alk<1>-X-Alk<2>-, O-Alk<1>-X-, O-Alk<1>-X-Alk<2>- or S-Alk<1>-X-; wherein X is a direct bond, -O-, -S-, C=O, -NR<8>- or Het<2>; R<7> is hydrogen, C1-6alkyl or Ar<2>methyl; R<8> is hydrogen, C1-6alkyl or Ar<2>methyl; Alk<1> is C1-6alkanediyl; Alk<2> is C1-4alkanediyl; Ar<1> and Ar<2> are optionally substituted phenyl; phenyl; Het<1> and Het<2> are optionally substituted heterocycles; having angiogenesis inhibiting activity; their preparation, compositions containing them and their use as a medicine.
Patent HU-0200048-A3 (HU)
Title: Sebocytes, sebocyte cell lines and applications thereof
IPC: A61K35/12
Filed: 1999-12-15
Abstract: Adipose cells (sebocytes) are described, The invention especially relates to sebaceous gland cells and to a sebaceous gland cell line with the property of being continuously grown over many sub-cultures. The sebocytes are excellently suited for useful applications.
Patent HU-0203075-A3 (HU)
Title: Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
IPC: A01N43/40
Filed: 2000-09-22
Abstract: Aromatic diamide derivative represented by the general formula (I) or a salt thereof and agricultural/herticultural composition containing the same as the active ingredient, <CHEM> wherein A<1> represents alkylene, alkenylene or alkynylene; B represents, CO- or -C(=N-OR<4>)- (wherein R<4> represents H, etc.); R<1> to R<3> represent each H, etc.; Q<1> to Q<5> represent each N or carbon; Y represents halogeno, etc.; m is from 0 to 5; and Z<1> and Z<2> represent each O or S.
Patent HU-0204049-A3 (HU)
Title: Compositions of combined active ingredients for treating glaucoma
IPC: A61K31/55
Filed: 2000-12-01
Abstract: An agent for the prophylaxis or treatment of glaucoma, which comprises an angiotensin II antagonist and at least one compound selected from adrenaline receptor blockers, prostaglandins and carbonic anhydrase inhibitors as active ingredients for simultaneous, separate or successive use of these active ingredients.
Patent HU-0303526-A3 (HU)
Title: Enantioselective synthesis of azetidinone intermediate compounds
IPC: C07D263/26
Filed: 2002-03-25
Abstract: The application relates to a process for preparing a compound of Formula IThis compound is an intermediate used to produce compounds that are useful as hypocholesterolemic agents in the treatment and prevention of atheroschlerosis.
Patent HU-9700806-A3 (HU)
Title: Matrix tablet allowing the prolonged release of the sodium salt of tianeptine and process for the preparation thereof
IPC: A61K47/02
Filed: 1997-04-24
Abstract: Tablet matrix in which sustained release of sodium tianeptine (I) is controlled using a polymeric cellulose derivative and a calcium salt is new.
Patent HU-9800022-A3 (HU)
Title: Device for connecting pipes or the likes to connection rail
IPC: F16L3/24
Filed: 1998-01-09
Abstract: The body (16) has an integral sprung element (22) pressing it away from the fixture rail (12) so that it is pre-tensioned to engage with the fixture rail. The basic body is a stamped out or bent metal sheet curved into an eyelet (14) which at one point has a fixture (32,34) for the pipe. The body has two slots (20) for the fixture rail. A sprung tongue (22) integrated in the basic body protrudes from the eyelet.
Patent HU-9900621-A3 (HU)
Title: 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives, process to prepare them and pharmaceuticals contg. the said compds.
IPC: C07D295/185
Filed: 1997-02-18
Abstract: 3,4-Disubstituted phenylethanolaminotetralincarboxamide derivatives represented by general formula (1) and their pharmacologically acceptable salts having a selective  beta 2-adrenergic receptor stimulating effect with a relieved burden on the heart such as a frequent pulse. In said formula, A represents lower alkylene; B represents amino, di(lower alkyl)amino or 3- to 7-membered alicyclic amino optionally containing oxygen in the ring; n is an integer of 1 or 2; the carbon atom marked with "*" means a carbon atom or the R- or S- configuration or a mixture thereof; and the carbon atom marked with "(S)" means a carbon atom of the S-configuration. These compounds are useful as a preventive for threatened abortion/premature birth, a bronchodilator and a pain-relieving and lithagogue agent in ureterolithiasis. <CHEM>
Patent HU-9901166-A3 (HU)
Title: Method and facility for reprocessing waste method and facility for reprocessing waste
IPC: C10J3/00
Filed: 1997-08-06
Abstract: Waste (such as domestic garbage, industrial waste, and bulky refuse) or sewage sludge is pretreated by pyrolysis under an oxygen-poor atmosphere to provide solid pyrolysis residues and a pyrolysis gas. The solid pyrolysis residues are mechanically treated to provide a coarse fraction and a fine fraction. The coarse fraction is mechanically separated and fed to a metal bath reactor containing a metal bath and a liquid slag floating on the metal bath. The fine fraction entrained in a carrier gas is fed via a nozzle in order to carburize the metal bath. The carburized metal bath functions to reduce metal oxides from the liquid slag floated thereon, thereby purifying the liquid slag. At least a portion of the pyrolysis gas is used to smelt and heat the liquid slag.
Patent HU-9901768-A3 (HU)
Title: Parenteral fluid delivery bag
IPC: A61J1/05
Filed: 1997-04-17
Abstract: A parenteral fluid delivery bag having a line set formed integral with the bag, the line set being peelably releasable from the remainder of the bag so as to assume a deployed position adapted to enter into fluid communication with a patient. In an alternate embodiment, a plurality of bags connected by an integrally formed wye-junction are adapted for delivery to a patient and retrieval of fluid from a patient.
Patent WO-0251027-A3 (WO)
Title: Commande de communication rf a faible portee
Inventor: BOUET STEPHANE
IPC: H04L1/08
Filed: 2001-11-08
Abstract: L'invention concerne un procédé et un système de commande de l'activité radiofréquence à faible puissance de terminaux, et notamment un procédé de sélection et d'activation d'un terminal sans fil. Un signal comprenant une indication de transmission est émis par un premier terminal. Un second terminal reçoit ce signal un certain nombre de fois et compare les indications de transmission reçues avec des valeurs d'indication prédéterminées. Lorsque la comparaison révèle qu'un nombre prédéterminé d'indications de transmission satisfaisantes ont été reçues par le second terminal, ledit second terminal commence une transmission. Les indications de transmission peuvent se présenter sous la forme de messages comprenant des parties de queue dotées d'un ensemble présélectionné d'états.
Patent WO-03057916-A3 (WO)
Title: Profils du cancer
Inventor: KATAGIRI TOYOMASA
IPC: C12Q1/68
Filed: 2003-01-09
Abstract: L'invention, qui a trait aux profils génétiques et aux marqueurs du cancer, fournit des systèmes et des méthodes de criblage de médicaments qui soignent efficacement des patients et des types spécifiques de cancers. Plus particulièrement, l'invention fournit un traitement personnalisé adapté au type de cancer de l'individu.
Patent WO-0245756-A3 (WO)
Title: Oxydation avancee de sources chimiques et biologiques dangereuses
Inventor: TRIBELSKY ZAMIR
IPC: A61L9/18
Filed: 2001-12-07
Abstract: L'invention concerne les technologies d'oxydation avancée (AOT) faisant appel à une plate-forme d'un procédé AOT déclenché et effectué par laser, ainsi qu'un procédé permettant l'oxydation avancée d'agents chimiques et biologiques dangereux dont on suspecte la présence dans certaines régions. La présente invention concerne également une variété d'utilisations dudit procédé et les environnements dans lesquels ce procédé peut être mis en oeuvre. Le procédé consiste principalement : (c) à diffuser, sur les régions à traiter, un nuage de gaz, des vapeurs, des microgouttelettes, des gouttelettes ou des bulles formés à partir d'au moins une solution liquide contenant au moins un type de substance oxydante photocatalytique ; et (d) à diriger à travers ledit nuage au moins un faisceau de lumière à haute intensité présentant une longueur d'onde allant entre 220 et 390 nanomètres afin de déclencher ledit nuage, provoquant ainsi une activation catalysée libérant des radicaux libres de ladite substance oxydante afin qu'ils réagissent avec lesdits agents chimiques ou biologiques. La présente invention concerne également divers types et modes de réalisation de systèmes et dispositifs faisant appel à ce procédé, y compris un générateur de bulles conçu pour mettre en oeuvre le procédé dans divers sites où des procédures de traitement conformes au procédé sont nécessaires.
Patent WO-03107540-A3 (WO)
Title: Transmit diversity for base stations
Inventor: ARGAMAN GIDEON
IPC: H04B7/06
Filed: 2003-06-12
Abstract: A method and corresponding upgrade kit, for enhancing a base station (10) having a CDMA air interface and a passive antenna (12) with receive space diversity capability so as to provide the base station with transmit diversity capability. The method comprises attaching a radio frequency interface unit to an R.F. output of the base station to obtain a sample of a main R.F. signal, attaching a diversity unit (20) to the radio frequency interface unit to generate a transmit diversity signal, and connecting the diversity unit to the passive antenna to transmit the transmit diversity signal.
Patent WO-0006579-A3 (WO)
Title: Pyrrolo[2,1-b]benzothiazepines presentant une activite antipsychotique atypique
Inventor: CAMPIANI GIUSEPPE
IPC: C07D513/04
Filed: 1999-07-27
Abstract: La présente invention concerne de nouveaux hétérocycles polycondensés à structure pyrrolo[2,1-b][1,3]benzothiazépines représentée par la formule (I), dans laquelle ces groupes sont tels que définis dans le descriptif. Par rapport aux agents antipsychotiques connus, les composés de cette invention présentent une importante activité associée à la diminution simultanée des symptômes extrapyramidaux indésirables. Ces composés peuvent être formulés dans des compositions pharmaceutiques destinées au traitement des psychoses telles que la schizophrénie, par exemple.
Patent WO-9928460-A3 (WO)
Title: Molecules ayant une interaction avec l'apoptine
Inventor: NOTEBORN MATHIEU HUBERTUS MARI
IPC: A61K38/00
Filed: 1998-12-03
Abstract: L'invention porte sur l'activation de l'apoptose par l'interférence de composés de type Hou et/ou de type IFP35. L'invention porte également sur des thérapies antitumorales utilisant des composés qui interfèrent négativement avec des composés de type Hou et/ou IFP35 conduisant à l'induction de l'apoptose et entraînant l'élimination des cellules tumorales. L'invention porte encore sur des thérapies s'appliquant aux maladies apparentées à l'induction de l'apoptose aberrante telles que des maladies autoimmunes. L'invention porte enfin sur le diagnostic des cellules sensibles à l'apoptose induite par l'apoptine ou une protéine analogue à l'apoptine.
Patent WO-9733448-A3 (WO)
Title: Reselection de canal de commande ou de canal pilote entre cellules appartenant a des zones d'enregistrement differentes
Inventor: SAWYER FRANCOIS
IPC: H04W60/04
Filed: 1997-02-26
Abstract: Dans un réseau téléphonique cellulaire (10) ARMT ou ARMC incluant plusieurs zones d'enregistrement (32), dans les cas de resélection de cellule de station mobile (16) entre une cellule (12) située dans une zone d'enregistrement et une cellule située dans une deuxième zone d'enregistrement, la station mobile effectue des mesures de puissance des signaux sur le canal de commande ou sur le canal pilote pour établir à la fois la valeur d'hystérésis de resélection classique (30) et une valeur d'hystérésis d'enregistrement additionnel (36). La resélection est effectuée par la station mobile lorsque la puissance des signaux sur le canal de commande ou sur le canal pilote mesurée (26) par rapport à la cellule de la deuxième zone d'enregistrement dépasse la puissance des signaux sur le canal de commande ou le canal pilote mesurée (24) par rapport à la cellule de la première zone d'enregistrement de la valeur totale des valeurs d'hystérésis de resélection et d'hystérésis d'enregistrement. Ceci rend plus difficile d'obtenir la resélection d'une cellule assignée à une zone entre enregistrements, ce qui contribue à atténuer la probabilité d'une consommation inutile de précieuses ressources d'interface cellulaires herziennes et de ressources du système qui résulte du transit d'aller-retour de la station mobile entre deux zones d'enregistrement.
Patent WO-0024217-A3 (WO)
Title: Transfert asynchrone via une liaison radio cellulaire
Inventor: KATINAKIS NIKOS
IPC: H04W72/02
Filed: 1999-10-05
Abstract: L'invention concerne un système et un procédé de transfert de données vers et depuis une station mobile (MS) (11) dans un réseau de télécommunication cellulaire (10). Lorsque la MS génère une transmission de données, la MS se réserve simultanément des canaux vocaux ou canaux de contrôle supplémentaires au départ de la cellule de service ou des cellules adjacentes, comble les créneaux de temps avec des paquets de données et transmet de manière asynchrone les paquets de données via la pluralité de canaux de manière à augmenter la vitesse de transfert des données. Pour des communications de données aboutissant à la MS, le central de desserte mobile (MSC) (15) se réserve une pluralité de canaux ayant une intensité de signal suffisante afin de maintenir une connexion avec la destination MS. Le MSC informe les stations de base concernées (12-14) qu'une transmission asynchrone va être effectuée vers la MS. Le MSC regroupe ensuite les paquets de données et lance la transmission à travers les stations de base concernées vers la MS via les canaux réservés. La MS regroupe les paquets selon un ordre numérique et transmet les données à l'utilisateur.
Patent SK-1262018-A3 (SK)
Inventor: MARTINČEK IVAN
IPC: G01N21/27
Filed: 2018-11-12
Abstract: Prehĺtací kapsulový endoskop obsahuje kapsulu (1) tvaru modifikovaného zrezaného kužeľa s dutinou, v ktorej je vložený endoskopický modul (A), ktorý obsahuje optický vstup na prenos dát tvorený optickou sústavou (7) napojenou na zobrazovaciu kameru (3) a zobrazovacia kamera (3) je na druhej strane napojená na plošný spoj (5), optická sústava (7) má po bokoch umiestnené osvetľovacie diódy (4), ku ktorým je tekutým epoxidom prilepený epoxidový polymérny valec (11), na plošný spoj (5) sú pripojené spájkovaním pomocou elektricky vodivých spojov (6) elektrické vodiče (9), ktoré sú vložené do dielektrickej ochrannej trubičky (10) a sú vyvedené z plošného spoja (5) endoskopického modulu (A), medzi optickou sústavou (7), zobrazovacou kamerou (3), epoxidovým polymérnym valcom (11) a osvetľovacími diódami (4) je vzduchová medzera (8) a zvyšok dutiny vnútri kapsuly (1) je vyplnený vytvrdeným dielektrickým polymérom (2), pričom zrezaný kužeľ kapsuly (1) je modifikovaný tak, že plocha podstavy kužeľa, na ktorej sa nachádza optický vstup kapsuly (1), je väčšia ako plocha opačnej podstavy kužeľa.
Patent SK-7742003-A3 (SK)
Inventor: HMIRAK STANISLAV
IPC: F16H15/04
Filed: 2003-06-18
Abstract: Prevodovka s plynulou zmenou prevodového pomeru má
rotačné nehomokinetické kĺby (1,2) alebo kĺbové sériovo
usporiadané sústavy, ktorých vyosením z rovnoosej polohy
dosiahneme zmenu prevodového pomeru z 1 : 1 do rýchla,
pričom po vyosení využíva zrýchľujúce zložky rotačnej
rýchlosti týchto kĺbov a spomaľujúce zložky sú eliminované
voľnobežkami (3), ktoré sú umiestnené za každým
kĺbom alebo kĺbovou sústavou. Kvôli rovnomernosti výsledného
pohybu je vhodné použiť planétovo po obvode
hnacieho kolesa usporiadané proti nehomokinetické kĺby
alebo kĺbové sústavy, kde má každá kĺbová sústava pootočený
začiatok nehomokinetického cyklu proti druhej, aby
bol výsledný pohyb rovnomerný. Vyosenie kĺbov môžeme
realizovať pootočením vnútornej časti prevodovky, alebo
vyosením celej hnacej sústavy proti hnanej. Po dosiahnutí
najrýchlejšieho prevodového pomeru môžeme jednoduchým
posunutím zubovej spojky prepojiť priamo vstupný
hriadeľ s výstupným a využiť prenos krútiaceho momentu
bez trecích strát v ozubeniach.
Patent SK-8682001-A3 (SK)
Title: New beta-amide and beta-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
Inventor: AMBERG WILHELM
IPC: A61K31/53
Filed: 1999-12-09
Abstract: The invention relates to carboxylic acid derivatives of formula (I), in which the substituents have the following meanings: R<1> is tetrazol or a group (a); W and Z, can be identical or different and are nitrogen or methine, provided that if W and Z are methine, then Q is nitrogen; X is nitrogen or CR<9>; Y is nitrogen or CR<10>; Q is nitrogen or CR<11>, provided that if Q is nitrogen then X is CR<5> and Y is CR<10>; R<2> and R<3> are identical or different and are possibly substituted phenyl or naphthyl or phenyl or naphthyl which are linked in an ortho position via a direct bond, a methlyene, ethylene or ethenylene group, an oxygen or sulfur atom or a SO2-, NH- or N-alkyl group or possibly substituted C5-C6-cycloalkyl; R<4> is a rest (b) or (c); and R<5> is hydrogen, C1-C4-alkyl. The invention further relates to their preparation and their use as endothelin receptor antagonists. The invention also relates to compounds of formula (II) and a structural fragment of formula (d) in which the rests R<1>, R<2>, R<3>, R<4> and R<5> have the meanings given in claim no. 1 and to their use as structural elements in an endothelin receptor antagonist.
Patent SK-9662002-A3 (SK)
Title: Method for reprocessing dust or dust mixtures
Inventor: EDLINGER ALFRED
IPC: C21B5/04
Filed: 2001-01-18
Abstract: The invention relates to a method for reprocessing dust or dust mixtures containing alkalis and heavy metals such as e.g., steel works dust, ore dusts or blast furnace dust. According to said method, the dust is introduced onto or into a bath consisting of liquid metals and liquid oxidic slag, especially by blasting. Volatile heavy metal compounds such as e.g., Zn- and/or Pb oxide are separated off from the gas phase and alkalis are introduced into slag.
Patent SU-880260-A3 (SU)
Inventor: AKSELSON ROLF
IPC: F04C18/16
Filed: 1973-06-18
Granted: 1981-11-07
Abstract: 1418069 Screw compressors STAL REFRIGERATION AB 22 June 1973 [30 June 1972] 29839/73 Heading F1F A screw compressor comprises a slide gate 8 having a convex surface which rests in the bottom 13 of a recess in the casing 1, and two concave surfaces which co-operate with corresponding surfaces 11, 12 in the outlet port 5, which surfaces 11, 12 prevent the gate 8 from rotating, the gate 8 being further supported by a rod 9 which is slidable in the casing 1. The rod 9 extends through gate 8 and is attached thereto by a spring washer 10. The slide gate 8 is controlled by a piston 15 in a cylinder 16, which piston acts on gate 8 via rod 17, plate 18 and rod 9 against which plate 18 abuts. Movement of gate 8 to the left uncovers opening 14 to vent gas via holes in plate 18 and a channel 19 back to the inlet 4. Cylinder 16 can be subjected to either the outlet or inlet pressure via lines 20, 21.
Patent SU-973008-A3 (SU)
Inventor: BITTI KHOREJS SMERT
IPC: B41J7/64
Filed: 1975-12-18
Granted: 1982-11-07
Abstract: 1487034 Printers INTERNATIONAL BUSINESS MACHINES CORP 16 Dec 1975 [30 Dec 1974] 51666/75 Heading G4H [Also in Division B6] A serial printer (see also Division B6) comprises a type bearing element (8, Fig. 1, not shown) mounted on a type carrier (10) which is driven along the print line by a constant speed motor (18), a further motor 26 applying corrections to the drive to the type carrier to provide for different time intervals between successive character selections. The type element (8) may be a continuously rotated disc, or a ball or stick. The motor 26 is a pulse driven stepping motor, receiving pulses from a decrementer 130 and driven in a direction controlled by control 132. The next character address is compared at 110 with the contents of a ROM 108 receiving codes from a counter 106 set initially at a value dependent on the previous character and incremented on unequal compare at 110. Each no match signal increments counter 116 controlling the direction control 132. Thus the type carrier is displaced at a rate such that the carrier arrives at the next print location at the time when the next character is in position for printing.
Patent SU-862822-A3 (SU)
Inventor: JENKO BRANKO
IPC: C07C277/08
Filed: 1979-04-25
Granted: 1981-09-07
Abstract: A process of preparing   <IMAGE>   by reacting 4-thiomethyl-5-methyl imidazole with N-cyano-N'-methyl-N''-(2-chloroethyl) guanidine in a two-phase system under the conditions of phase transfer catalysis.
Patent SU-1715207-A3 (SU)
Inventor: KHEFELE JOZEF
IPC: C08L23/00
Filed: 1984-10-01
Granted: 1992-02-23
Abstract: The invention concerns a heat-sealing adhesive on the basis of copolyamides for the coating of fabrics, and especially of linings for outerwear. The invention consists of the fact that this heat-sealing adhesive contains from 0.3 to 15% by weight, preferably 0.7 to 12% by weight, of behenic acid. Thereby a substantially and unexpectedly increased adhesion strength of the adhesive is attained, so that for the same adhesive strength a smaller amount of the heat-sealing adhesive is required. This improves the comfort provided by the article of clothing when being worn. The invention also concerns a process for the manufacture of this heat-sealing adhesive as well as its use for the coating of lining fabrics.